Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.

Fok, J S; Katelaris, C H; Brown, A F; Smith, W B

Fok, J S; Katelaris, C H; Brown, A F; Smith, W B.

Affiliation

Fok JS; Department of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Katelaris CH; Department of Clinical Immunology and Allergy, Campbelltown Hospital, Sydney, New South Wales, Australia.
Brown AF; University of Western Sydney, Sydney, New South Wales, Australia.
Smith WB; School of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Intern Med J ; 45(8): 821-7, 2015 Aug.

Article in En | MEDLINE | ID: mdl-25944565

Subject(s)

Angioedema/drug therapy; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Bradykinin B2 Receptor Antagonists/therapeutic use; Bradykinin/analogs & derivatives; Adult; Aged; Aged, 80 and over; Angioedema/chemically induced; Bradykinin/therapeutic use; Clinical Decision-Making/methods; Emergency Service, Hospital/standards; Female; Humans; Intubation, Intratracheal; Larynx/pathology; Male; Middle Aged; Oropharynx/pathology

Key words

airway angioedema; angiotensin-converting enzyme inhibitor; emergency department; icatibant; intubation

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bradykinin / Angiotensin-Converting Enzyme Inhibitors / Bradykinin B2 Receptor Antagonists / Angioedema Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Intern Med J Journal subject: MEDICINA INTERNA Year: 2015 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google